Chronicle Journal: Finance

Eli Lilly starts late-stage study of coronavirus drug in nursing homes

U.S. drugmaker Eli Lilly said on Monday it is beginning a late-stage trial to study whether one of its experimental Covid-19 antibody treatments can prevent the virus' spread in residents and staff in U.S. nursing homes.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.